Highlights
- Today’s Research Article: PRP Beats Steroids for Chronic Heel Pain — And the Results Last!
- Questions from the Field: PRP Relief Can Last Over a Year — Backed by Real-World Data.
- Let’s Get Down to Business: Ditch the Burnout — A Cash Practice Can Set You Free.
- Come Join Us: Learn, Network, and Grow — Join Us Live in Vegas!
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial
Krishan Kumar, Vikas Rao, Amrit Panda, Sathyendra K.G., Harshvardhan Buddhist
Summary:
This randomized controlled trial compared the effectiveness of platelet-rich plasma (PRP) injections versus corticosteroid injections in 70 patients with chronic plantar fasciitis who had not improved after three months of conservative treatment. Both groups started with similar pain and function levels, but the PRP group showed significantly better improvements in pain scores (VAS) and functional outcomes (AOFAS) at 1, 3, and 6 months post-treatment. No adverse events were reported in either group.
The study concluded that autologous PRP injections offer superior long-term relief compared to corticosteroids. PRP’s regenerative capabilities — driven by concentrated growth factors — provide more sustained healing, addressing the underlying degeneration in plantar fascia tissue, unlike corticosteroids which mainly offer short-term symptom control. This makes PRP a compelling option for patients with persistent heel pain who have failed conventional therapies.
Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):
